nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2A6—Ifosfamide—testicular cancer	0.414	0.448	CbGbCtD
Chlorzoxazone—CYP2E1—Etoposide—testicular cancer	0.131	0.141	CbGbCtD
Chlorzoxazone—CYP3A4—Ifosfamide—testicular cancer	0.0829	0.0895	CbGbCtD
Chlorzoxazone—CYP1A2—Etoposide—testicular cancer	0.0756	0.0817	CbGbCtD
Chlorzoxazone—CYP2D6—Vinblastine—testicular cancer	0.0691	0.0747	CbGbCtD
Chlorzoxazone—CYP3A4—Vinblastine—testicular cancer	0.044	0.0475	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—testicular cancer	0.0425	0.0459	CbGbCtD
Chlorzoxazone—CYP3A4—Etoposide—testicular cancer	0.0396	0.0428	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—testicular cancer	0.027	0.0292	CbGbCtD
Chlorzoxazone—Digestion impaired—Chlorambucil—testicular cancer	0.00548	0.0739	CcSEcCtD
Chlorzoxazone—Petechiae—Ifosfamide—testicular cancer	0.00295	0.0397	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.00176	0.0237	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00152	0.0204	CcSEcCtD
Chlorzoxazone—Angioedema—Chlorambucil—testicular cancer	0.00146	0.0197	CcSEcCtD
Chlorzoxazone—Petechiae—Methotrexate—testicular cancer	0.00139	0.0188	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Vinblastine—testicular cancer	0.00136	0.0184	CcSEcCtD
Chlorzoxazone—Malaise—Vinblastine—testicular cancer	0.00132	0.0178	CcSEcCtD
Chlorzoxazone—Petechiae—Epirubicin—testicular cancer	0.0013	0.0176	CcSEcCtD
Chlorzoxazone—Discomfort—Vinblastine—testicular cancer	0.00123	0.0166	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—testicular cancer	0.00121	0.0163	CcSEcCtD
Chlorzoxazone—Dyspepsia—Chlorambucil—testicular cancer	0.00115	0.0155	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Bleomycin—testicular cancer	0.00115	0.0155	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00113	0.0152	CcSEcCtD
Chlorzoxazone—Malaise—Bleomycin—testicular cancer	0.00112	0.0151	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Chlorambucil—testicular cancer	0.00108	0.0145	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Dactinomycin—testicular cancer	0.00107	0.0145	CcSEcCtD
Chlorzoxazone—Discomfort—Bleomycin—testicular cancer	0.00104	0.0141	CcSEcCtD
Chlorzoxazone—Malaise—Dactinomycin—testicular cancer	0.00104	0.0141	CcSEcCtD
Chlorzoxazone—Ecchymosis—Methotrexate—testicular cancer	0.00104	0.014	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Bleomycin—testicular cancer	0.00101	0.0136	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Vinblastine—testicular cancer	0.000987	0.0133	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Ifosfamide—testicular cancer	0.000983	0.0132	CcSEcCtD
Chlorzoxazone—Discomfort—Dactinomycin—testicular cancer	0.000973	0.0131	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—testicular cancer	0.00097	0.0131	CcSEcCtD
Chlorzoxazone—Angioedema—Ifosfamide—testicular cancer	0.000968	0.013	CcSEcCtD
Chlorzoxazone—Malaise—Ifosfamide—testicular cancer	0.000956	0.0129	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—testicular cancer	0.000898	0.0121	CcSEcCtD
Chlorzoxazone—Discomfort—Ifosfamide—testicular cancer	0.000891	0.012	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Ifosfamide—testicular cancer	0.000865	0.0117	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cisplatin—testicular cancer	0.000848	0.0114	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Bleomycin—testicular cancer	0.000834	0.0112	CcSEcCtD
Chlorzoxazone—Malaise—Cisplatin—testicular cancer	0.000824	0.0111	CcSEcCtD
Chlorzoxazone—Dizziness—Vinblastine—testicular cancer	0.000792	0.0107	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000779	0.0105	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Dactinomycin—testicular cancer	0.000778	0.0105	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Etoposide—testicular cancer	0.000777	0.0105	CcSEcCtD
Chlorzoxazone—Somnolence—Ifosfamide—testicular cancer	0.000769	0.0104	CcSEcCtD
Chlorzoxazone—Discomfort—Cisplatin—testicular cancer	0.000768	0.0104	CcSEcCtD
Chlorzoxazone—Malaise—Etoposide—testicular cancer	0.000755	0.0102	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000747	0.0101	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Cisplatin—testicular cancer	0.000746	0.01	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000721	0.00971	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Ifosfamide—testicular cancer	0.000713	0.0096	CcSEcCtD
Chlorzoxazone—Discomfort—Etoposide—testicular cancer	0.000704	0.00949	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Etoposide—testicular cancer	0.000683	0.0092	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000644	0.00867	CcSEcCtD
Chlorzoxazone—Drowsiness—Methotrexate—testicular cancer	0.000642	0.00864	CcSEcCtD
Chlorzoxazone—Rash—Bleomycin—testicular cancer	0.000638	0.0086	CcSEcCtD
Chlorzoxazone—Dermatitis—Bleomycin—testicular cancer	0.000637	0.00859	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Cisplatin—testicular cancer	0.000614	0.00828	CcSEcCtD
Chlorzoxazone—Somnolence—Etoposide—testicular cancer	0.000607	0.00818	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—testicular cancer	0.0006	0.00809	CcSEcCtD
Chlorzoxazone—Rash—Dactinomycin—testicular cancer	0.000595	0.00802	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Etoposide—testicular cancer	0.00059	0.00795	CcSEcCtD
Chlorzoxazone—Dizziness—Ifosfamide—testicular cancer	0.000572	0.00771	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Etoposide—testicular cancer	0.000563	0.00758	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—testicular cancer	0.000556	0.00748	CcSEcCtD
Chlorzoxazone—Rash—Ifosfamide—testicular cancer	0.000545	0.00735	CcSEcCtD
Chlorzoxazone—Dermatitis—Ifosfamide—testicular cancer	0.000545	0.00734	CcSEcCtD
Chlorzoxazone—Rash—Cisplatin—testicular cancer	0.00047	0.00633	CcSEcCtD
Chlorzoxazone—Dermatitis—Cisplatin—testicular cancer	0.00047	0.00633	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Methotrexate—testicular cancer	0.000465	0.00627	CcSEcCtD
Chlorzoxazone—Malaise—Methotrexate—testicular cancer	0.000452	0.00609	CcSEcCtD
Chlorzoxazone—Dizziness—Etoposide—testicular cancer	0.000452	0.00609	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—testicular cancer	0.000435	0.00586	CcSEcCtD
Chlorzoxazone—Rash—Etoposide—testicular cancer	0.000431	0.0058	CcSEcCtD
Chlorzoxazone—Dermatitis—Etoposide—testicular cancer	0.00043	0.0058	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—testicular cancer	0.000423	0.0057	CcSEcCtD
Chlorzoxazone—Discomfort—Methotrexate—testicular cancer	0.000422	0.00568	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methotrexate—testicular cancer	0.000409	0.00551	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000403	0.00543	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—testicular cancer	0.000395	0.00532	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—testicular cancer	0.000391	0.00527	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—testicular cancer	0.000383	0.00516	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—testicular cancer	0.000365	0.00492	CcSEcCtD
Chlorzoxazone—Somnolence—Methotrexate—testicular cancer	0.000364	0.0049	CcSEcCtD
Chlorzoxazone—Dyspepsia—Methotrexate—testicular cancer	0.00036	0.00485	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000354	0.00477	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000353	0.00476	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—testicular cancer	0.00034	0.00459	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Methotrexate—testicular cancer	0.000337	0.00454	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—testicular cancer	0.000337	0.00454	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000331	0.00445	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—testicular cancer	0.000316	0.00425	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—testicular cancer	0.000315	0.00424	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—testicular cancer	0.000312	0.0042	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000306	0.00412	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—testicular cancer	0.000292	0.00393	CcSEcCtD
Chlorzoxazone—Dizziness—Methotrexate—testicular cancer	0.000271	0.00365	CcSEcCtD
Chlorzoxazone—Rash—Methotrexate—testicular cancer	0.000258	0.00348	CcSEcCtD
Chlorzoxazone—Dermatitis—Methotrexate—testicular cancer	0.000258	0.00347	CcSEcCtD
Chlorzoxazone—Dizziness—Epirubicin—testicular cancer	0.000253	0.00341	CcSEcCtD
Chlorzoxazone—Rash—Epirubicin—testicular cancer	0.000241	0.00325	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—testicular cancer	0.000241	0.00325	CcSEcCtD
Chlorzoxazone—Dizziness—Doxorubicin—testicular cancer	0.000234	0.00316	CcSEcCtD
Chlorzoxazone—Rash—Doxorubicin—testicular cancer	0.000223	0.00301	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—testicular cancer	0.000223	0.00301	CcSEcCtD
